Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · May 29, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The primary objective of this study is to examine a single-session, 2-hour group intervention provided to a population of transgender and gender-diverse patients with chronic pain prior to gender-affirming surgery, to determine if participants who receive the intervention have less pain-related distress compared to participants randomly assigned to the control group. This study will help extend the research literature on chronic pain experienced by transgender patients, and specifically will examine if a brief, group intervention is effective for reducing pain catastrophizing and pain distr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. affiliated with the OHSU Transgender Health Program and have completed their initial consultation for gender-affirming surgery,
- • 2. who have chronic pain (defined as \> 3 months of pain),
- • 3. who rate their average level of pain intensity as at least a 4 or higher (on 0-10 pain scale)
- • 4. who have fluency in English. Empowered Relief may only be delivered by a certified instructor, and for this research study the instructor is only able to offer the curriculum in English.
- Exclusion Criteria:
- • 1. have had a pain-focused behavioral therapy in the past year, or
- • 2. have severe depression and/or moderate or higher risk of suicidality based on the person's score on the PHQ-9 greater than 20.
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0